US: Advancements in Autoantibody Testing for Thyroid Conditions

Activity Title

Advancements in Autoantibody Testing for Thyroid Conditions

Statement of Need/Program Overview

This educational activity will examine autoimmune related causality of thyroid dysfunction, and how testing for autoantibodies to the thyroid stimulating hormone receptor (TSHR) contribute to making an accurate diagnosis. Standard laboratory methods to determine functional activity of anti-TSHR will be discussed, along with anticipated bioassay advancements.

Target Audience

This activity is intended for medical professionals who have a clinical interest in thyroid disorders as seen in the following medical specialties: endocrinology, primary care (IM, FP, GP), obstetrics/gynecology, cardiology, pediatrics, laboratory medicine, nuclear medicine, ophthalmology, neurology, psychiatry, and sleep medicine.

Educational Objectives

After completing the activity, the participant should be better able to:

Explain the connection between thyroid autoantibodies and the thyroid stimulating hormone receptor.
Differentiate between critical thyroid laboratory tests such as binding assays, and bioassays that detect anti-TSHR antibodies.
Analyze current anti-TSHR testing versus developing anti-TSHR bioassays.

Faculty

Paul D. Olivo, MD, PhD
Immunologist and Molecular Biologist
Adjunct Assistant Professor
Department of Molecular Microbiology and Microbial Pathogenesis
Washington University Medical School
St. Louis, Missouri

Program Agenda

Educational Presentation (62 minutes)
Post Test and Evaluation (5 minutes)
Total Activity: (67 minutes)

CME Provider Accreditation Statement (MHI)

MHI Logo This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the providership of Metabolic Health Initiative (MHI). MHI is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement (MHI)

Metabolic Health Initiative designates this Enduring Material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to: 1.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Non-physician Attendance: A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

Term Offering

This activity was released on May 15, 2026 and is valid for one year. Requests for credit must be made no later than May 15, 2027.

Metabolic Health Initiative Contact Information

For information about the accreditation of this program, please contact Metabolic Health Initiative via email at info@metabolicinitiative.com

American Academy of Family Physicians (AAFP) Accreditation

The AAFP has reviewed Advancements in Autoantibody Testing for Thyroid Conditions and deemed it acceptable for up to 1.00 Enduring Materials, Self-Study AAFP Prescribed credit(s). Term of Approval is from 05/15/2026 to 05/15/2027. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Instructions to Receive Credit

In order to receive credit, participants must complete the course, score at least a 70% on the post test, complete the course evaluation form, and submit a credit application. Successful applicants will be able to download their certificate upon completion of these requirements. A copy of the certificate will also be sent to the email address provided in the credit application.

System Requirements

To view this educational activity, you will need a web browser with JavaScript and either Flash or HTML5 enabled. Nearly all modern web browsers will work.

Fee Information

There is no fee for this educational activity.

Disclosure of Relevant Financial Relationships

It is the policy of Metabolic Health Initiative to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. Metabolic Health Initiative assesses relevant conflict of interest with its faculty, planners and managers of educational activities. Conflicts of interest that are identified are resolved by reviewing that presenter’s content for fair balance and absence of bias, scientific objectivity of studies utilized in this activity, and
patient care recommendations.

While Metabolic Health Initiative endeavors to review faculty content, it remains the obligation of each physician or other healthcare practitioner to determine the applicability or relevance of the information provided from this course in his or her own practice.

In accordance with the policy of Metabolic Health Initiative, faculty are asked to disclose any and all relevant financial relationships that may affect the content of their presentations.

Faculty Disclosures

The faculty have the following relevant financial relationships with ineligible companies:

Paul D. Olivo, MD, PhD
- Consultant Fee (e.g., Advisory Board): QuidelOrtho Corp
- Royalty: QuidelOrtho Corp

All relevant financial relationships have been mitigated.

The planners and managers at Metabolic Health Initiative have no relevant financial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Metabolic Health Initiative (MHI) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Metabolic Health Initiative (MHI) protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. MHI and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Metabolic Health Initiative and Dane Garvin Ltd. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.